FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2580453625> ?p ?o ?g. }

• W2580453625 abstract "Less than one-third of patients who are estimated to be infected with multidrug-resistant tuberculosis (MDR-TB) receive MDR-TB treatment regimens, and only 48% of those who received treatment have successful outcomes. Despite current regimens, newer, more effective and cost-effective approaches to treatment are needed. The aim of the study was to project health outcomes and impact on healthcare resources of adding bedaquiline to the treatment regimen of MDR-TB in selected high burden countries: Estonia, Russia, South Africa, Peru, China, the Philippines, and India.This study adapted an existing Markov model to estimate the health outcomes and impact on total healthcare costs of adding bedaquiline to current MDR-TB treatment regimens. A price threshold analysis was conducted to determine the price range at which bedaquiline would be cost-effective.Adding bedaquiline to the background regimen (BR) resulted in increased disability-adjusted life years (DALYs) averted, and reduced total healthcare costs (excluding treatment acquisition costs) compared with BR alone in all countries analyzed. Addition of bedaquiline to BR resulted in savings to healthcare costs compared with BR alone in all countries analyzed, with the highest impact expected in Russia (US$194 million) and South Africa (US$43 million). The price per regimen at which bedaquiline would be cost-effective ranged between US$23,904-US$203,492 in Estonia, Russia, Peru, South Africa, and China (high and upper middle-income countries) and between US$6,996-US$20,323 in the Philippines and India (lower middle-income countries); however, these cost-effective prices do not necessarily address concerns about affordability.Adding bedaquiline to BR provides improvements in health outcomes and reductions in healthcare costs in high MDR-TB burden countries. The range of prices per regimen for which bedaquiline would be cost-effective varied between countries." @default.
• W2580453625 created "2017-02-03" @default.
• W2580453625 creator A5024491186 @default.
• W2580453625 creator A5031183649 @default.
• W2580453625 creator A5034785698 @default.
• W2580453625 creator A5040765620 @default.
• W2580453625 creator A5088490636 @default.
• W2580453625 date "2017-01-26" @default.
• W2580453625 modified "2023-10-09" @default.
• W2580453625 title "Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries" @default.
• W2580453625 cites W11309145 @default.
• W2580453625 cites W1987856430 @default.
• W2580453625 cites W2004143136 @default.
• W2580453625 cites W2006498668 @default.
• W2580453625 cites W2019744795 @default.
• W2580453625 cites W2027017781 @default.
• W2580453625 cites W2029036450 @default.
• W2580453625 cites W2042420590 @default.
• W2580453625 cites W2078212305 @default.
• W2580453625 cites W2108215795 @default.
• W2580453625 cites W2138041013 @default.
• W2580453625 cites W2171008074 @default.
• W2580453625 cites W2318000940 @default.
• W2580453625 cites W4299856298 @default.
• W2580453625 doi "https://doi.org/10.1186/s12913-016-1931-3" @default.
• W2580453625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5267460" @default.
• W2580453625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28122562" @default.
• W2580453625 hasPublicationYear "2017" @default.
• W2580453625 type Work @default.
• W2580453625 sameAs 2580453625 @default.
• W2580453625 citedByCount "22" @default.
• W2580453625 countsByYear W25804536252017 @default.
• W2580453625 countsByYear W25804536252018 @default.
• W2580453625 countsByYear W25804536252019 @default.
• W2580453625 countsByYear W25804536252020 @default.
• W2580453625 countsByYear W25804536252021 @default.
• W2580453625 countsByYear W25804536252022 @default.
• W2580453625 countsByYear W25804536252023 @default.
• W2580453625 crossrefType "journal-article" @default.
• W2580453625 hasAuthorship W2580453625A5024491186 @default.
• W2580453625 hasAuthorship W2580453625A5031183649 @default.
• W2580453625 hasAuthorship W2580453625A5034785698 @default.
• W2580453625 hasAuthorship W2580453625A5040765620 @default.
• W2580453625 hasAuthorship W2580453625A5088490636 @default.
• W2580453625 hasBestOaLocation W25804536251 @default.
• W2580453625 hasConcept C121955636 @default.
• W2580453625 hasConcept C137992405 @default.
• W2580453625 hasConcept C138816342 @default.
• W2580453625 hasConcept C141071460 @default.
• W2580453625 hasConcept C142724271 @default.
• W2580453625 hasConcept C144133560 @default.
• W2580453625 hasConcept C159110408 @default.
• W2580453625 hasConcept C160735492 @default.
• W2580453625 hasConcept C162324750 @default.
• W2580453625 hasConcept C182299520 @default.
• W2580453625 hasConcept C2777975735 @default.
• W2580453625 hasConcept C2780544761 @default.
• W2580453625 hasConcept C2781069245 @default.
• W2580453625 hasConcept C2781413609 @default.
• W2580453625 hasConcept C50522688 @default.
• W2580453625 hasConcept C524218345 @default.
• W2580453625 hasConcept C71924100 @default.
• W2580453625 hasConcept C83864248 @default.
• W2580453625 hasConcept C99454951 @default.
• W2580453625 hasConceptScore W2580453625C121955636 @default.
• W2580453625 hasConceptScore W2580453625C137992405 @default.
• W2580453625 hasConceptScore W2580453625C138816342 @default.
• W2580453625 hasConceptScore W2580453625C141071460 @default.
• W2580453625 hasConceptScore W2580453625C142724271 @default.
• W2580453625 hasConceptScore W2580453625C144133560 @default.
• W2580453625 hasConceptScore W2580453625C159110408 @default.
• W2580453625 hasConceptScore W2580453625C160735492 @default.
• W2580453625 hasConceptScore W2580453625C162324750 @default.
• W2580453625 hasConceptScore W2580453625C182299520 @default.
• W2580453625 hasConceptScore W2580453625C2777975735 @default.
• W2580453625 hasConceptScore W2580453625C2780544761 @default.
• W2580453625 hasConceptScore W2580453625C2781069245 @default.
• W2580453625 hasConceptScore W2580453625C2781413609 @default.
• W2580453625 hasConceptScore W2580453625C50522688 @default.
• W2580453625 hasConceptScore W2580453625C524218345 @default.
• W2580453625 hasConceptScore W2580453625C71924100 @default.
• W2580453625 hasConceptScore W2580453625C83864248 @default.
• W2580453625 hasConceptScore W2580453625C99454951 @default.
• W2580453625 hasIssue "1" @default.
• W2580453625 hasLocation W25804536251 @default.
• W2580453625 hasLocation W25804536252 @default.
• W2580453625 hasLocation W25804536253 @default.
• W2580453625 hasLocation W25804536254 @default.
• W2580453625 hasOpenAccess W2580453625 @default.
• W2580453625 hasPrimaryLocation W25804536251 @default.
• W2580453625 hasRelatedWork W2001296149 @default.
• W2580453625 hasRelatedWork W2125648033 @default.
• W2580453625 hasRelatedWork W2416980606 @default.
• W2580453625 hasRelatedWork W2580453625 @default.
• W2580453625 hasRelatedWork W2592677275 @default.
• W2580453625 hasRelatedWork W2807439384 @default.
• W2580453625 hasRelatedWork W2922915119 @default.
• W2580453625 hasRelatedWork W2995907519 @default.
• W2580453625 hasRelatedWork W3011308260 @default.
• W2580453625 hasRelatedWork W4248412978 @default.

• next